iPS Cells: New Applications for Metabolic Liver Diseases

2012 ◽  
pp. 85-95
Author(s):  
Tobias Cantz ◽  
Abbas Beh-Pajooh ◽  
Malte Sgodda
2019 ◽  
Vol 25 (35) ◽  
pp. 3740-3750 ◽  
Author(s):  
Ning Sun ◽  
Dongli Li ◽  
Xiaoqing Chen ◽  
Panpan Wu ◽  
Yu-Jing Lu ◽  
...  

Oleanolic acid is an analogue of pentacyclic triterpenoids. It has been used as a hepatic drug for over 20 years in China. Currently, there are only five approved drugs derived from pentacyclic triterpenoids, including oleanolic acid (liver diseases), asiaticoside (wound healing), glycyrrhizinate (liver diseases), isoglycyrrhizinate (liver disease) and sodium aescinate (hydrocephalus). To understand more about the bioactivity and functional mechanisms of oleanolic acid, it can be developed as a potent therapeutic agent, in particular, for the prevention and treatment of heart diseases that are the leading cause of death for people worldwide. The primary aim of this mini-review is to summarize the new applications of oleanolic acid and its derivatives as cardioprotective agents reported in recent years and to highlight their therapeutic perspectives in cardiovascular diseases.


2021 ◽  
Vol 11 (6) ◽  
pp. 161-179
Author(s):  
Jagadeesh Menon ◽  
Mukul Vij ◽  
Deepti Sachan ◽  
Ashwin Rammohan ◽  
Naresh Shanmugam ◽  
...  

1999 ◽  
Vol 79 (1) ◽  
pp. 153-162 ◽  
Author(s):  
Ajai Khanna ◽  
Ashok Jain ◽  
Bijan Eghtesad ◽  
Jorge Rakela

2006 ◽  
Vol 12 (S3) ◽  
pp. S124-S127 ◽  
Author(s):  
Sue McDiarmid ◽  
Robert G. Gish ◽  
Simon Horslen ◽  
George V. Mazariegos

2019 ◽  
Vol 178 (4) ◽  
pp. 515-523 ◽  
Author(s):  
Helena Moreira-Silva ◽  
Inês Maio ◽  
Anabela Bandeira ◽  
Esmeralda Gomes-Martins ◽  
Ermelinda Santos-Silva

2017 ◽  
Vol 20 (2) ◽  
pp. 176-181 ◽  
Author(s):  
Zahida Khan ◽  
Veena L Venkat ◽  
Kyle A Soltys ◽  
Donna B Stolz ◽  
Sarangarajan Ranganathan

Jaundice in the newborn period can be physiologic and is often due to benign causes. Jaundice due to conjugated hyperbilirubinemia extending beyond the second week of life may be an early sign of several cholestatic or metabolic liver diseases, and it requires logical and timely analysis so that specific treatments can be initiated. Alpha-1 antitrypsin deficiency is the most common genetic cause of pediatric liver disease and transplantation, and it must be considered when evaluating cholestatic infants. Here, we present an unusual case of alpha-1 antitrypsin deficiency with severe infantile cholestasis and rapid decompensation in the first 4 months of life, where in-depth but timely diagnosis was crucial for the appropriate intervention to take place.


Sign in / Sign up

Export Citation Format

Share Document